Trials / Completed
CompletedNCT00938548
Perioperative Administration of Pregabalin for Pain After Mastectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Severance Hospital · Academic / Other
- Sex
- Female
- Age
- 21 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following total mastectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be VNRS at 1 week and 1 month after operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Pregabalin 75 mg orally |
| DRUG | Vitamin Complex (placebo) | Vitamin Complex orally |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-12-01
- Completion
- 2010-01-01
- First posted
- 2009-07-14
- Last updated
- 2010-05-25
- Results posted
- 2010-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00938548. Inclusion in this directory is not an endorsement.